Fig. 2
From: Laparoscopic repeat liver resection for hepatic epithelioid hemangioendothelioma
a–c Gadolinium–ethoxybenzyl–diethylenetriamine–pentaacetic acid (Gd–EOB–DTPA) enhanced magnetic resonance imaging (MRI) revealed five tumors including a 15-mm tumor in the lateral superior segment (S2) (a, arrow), a 20-mm tumor in the anterior superior segment (S8) (b, arrowhead), a 16-mm (c, arrow) tumor and a 20-mm tumor (c, arrow) in the lateral inferior segment (S3), a 10-mm tumor in the posterior superior segment (S7) (c, arrowhead). d–f T2-weighted MRI revealed six tumors including a 15-mm tumor in S2 (d, arrow), a 16-mm (e, arrow) tumor and a 20-mm tumor (f, arrow) in S3, a 3-mm tumor and a 10-mm tumor in S7 (e, arrowheads), and a 20-mm tumor in S8 (d, arrowhead). A typical target sign was observed in the tumors in S2 (d, arrow) and S8 (d, arrowhead). g–i Enhanced 2-[18F] fluoro-2-deoxy-d-glucose (FDG) positron emission tomography showed FDG uptake in all tumors except one 3-mm tumor in S7